Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
Matthew J. Hadfield, Howard Safran, Marco A. Purbhoo, Joseph E. Grossman, Jennifer S. Buell, Benedito A. Carneiro
Topics & Concepts
BiologyImmune systemCancer researchImmunologyNatural killer T cellImmunotherapyCancerNatural killer cellImmune checkpointBlockadeCytotoxicityT cellReceptorIn vitroBiochemistryGeneticsImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersCAR-T cell therapy research